Tangular Barnes
Psychiatric/Mental Health · Gulfport, MSNPI 1902294093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 466 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2021 at $2,903 and has fallen 92.4% since, to $222 in 2025. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$782
- Teva Pharmaceuticals USA, Inc.$715
- Otsuka America Pharmaceutical, Inc.$706
- Neurocrine Biosciences, Inc.$594
- plus $2K from 11 others
What the payments were for
- Food & beverage$8,68899%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 133 | $2,176 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 58 | $1,359 |
| Alkermes, Inc. | 28 | $782 |
| Teva Pharmaceuticals USA, Inc. | 43 | $715 |
| Otsuka America Pharmaceutical, Inc. | 23 | $706 |
| Neurocrine Biosciences, Inc. | 44 | $594 |
| Lundbeck LLC | 33 | $510 |
| Johnson & Johnson | 23 | $479 |
| Vanda Pharmaceuticals Inc. | 15 | $399 |
| Sunovion Pharmaceuticals Inc. | 35 | $378 |
| Indivior Inc. | 15 | $282 |
| Idorsia Pharmaceuticals US Inc | 1 | $92 |
| Supernus Pharmaceuticals, Inc. | 4 | $90 |
| Avanir Pharmaceuticals, Inc. | 5 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Almatica Pharma LLC | 2 | $37 |
| Corium, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$868
- ARISTADA$500
- CAPLYTA$492
- VRAYLAR$219
- ARISTADA INITIO$125
- ABILIFY MAINTENA$125
- INGREZZA$125
- UZEDY$115
- INVEGA SUSTENNA$113
How this compares
$8,740 in reported general payments places this provider in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 16 | $22,155 |
| CaplytaLumateperone Tosylate | 13 | $20,584 |
| Sertraline Hcl | 13 | $625 |
| Oxcarbazepine | 11 | $343 |
| Quetiapine Fumarate | 28 | $278 |
| Aripiprazole | 29 | $248 |
| Hydroxyzine Pamoate | 21 | $238 |
| Mirtazapine | 30 | $216 |
| Lamotrigine | 17 | $85 |
| Buspirone Hcl | 15 | $85 |
| Trazodone Hcl | 23 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,176 | $22,15516 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,359 | $20,58413 claims |
| Almatica Pharma LLCSertraline Hcl | $37 | $62513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Gulfport
- Desiree NormanGulfport$10K
- Anita HallGulfport$8K
- Belinda HoldenGulfport$7K
- Chantal SullivanGulfport$7K
- Anne TuckerGulfport$5K
- Kari WilliamsGulfport$4K
- Jo DrennanGulfport$4K
- Elizabeth GarrigaGulfport$4K
- Ashley KarelVicksburg$129K
- Amanda HamCorinth$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.